An Assay for Periplasm Entry Advances the Development of Chimeric Peptide Antibiotics
- 22 July 2020
- journal article
- letter
- Published by American Chemical Society (ACS) in ACS Infectious Diseases
- Vol. 6 (9) , 2355-2361
Abstract
Treating infection by Gram-negative bacteria is increasingly challenging as resistance to existing antibiotics spreads. Constrained peptides, selected for high target specificity and affinity via library display technologies, are an emerging therapeutic modality in many disease areas and may be a fertile source of new antibiotics. Currently, the utility of constrained peptides and other large molecules as antibiotics is limited by the outer membrane (OM) barrier of Gram-negative bacteria. However, adding certain moieties to large molecules can confer the ability to cross the OM – these moieties function as intramolecular trans-OM “vectors”. Here, we present a method to systematically assess the carrying capacity of candidate trans-OM vectors using a real-time luminescence assay (“SLALOM”), reporting on periplasmic entry. We demonstrate the usefulness of our tools by constructing a 3800 Da chimeric compound comprised of a constrained bicyclic peptide (Bicycle®), with a periplasmic target, linked to an intramolecular peptide vector, the resulting chimera is a broad-spectrum inhibitor of pathogenic Gram-negative bacterial growth.Keywords
This publication has 26 references indexed in Scilit:
- NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in CellsACS Chemical Biology, 2015
- Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone SubstrateACS Chemical Biology, 2012
- Spontaneous Membrane-Translocating Peptides by Orthogonal High-Throughput ScreeningJournal of the American Chemical Society, 2011
- Phage-encoded combinatorial chemical libraries based on bicyclic peptidesNature Chemical Biology, 2009
- Siderophores as drug delivery agents: application of the “Trojan Horse” strategyBioMetals, 2009
- Siderophore Peptide, a New Type of Post-translationally Modified Antibacterial Peptide with Potent ActivityJournal of Biological Chemistry, 2004
- Screening System for Xenosiderophores as Potential Drug Delivery Agents in MycobacteriaAntimicrobial Agents and Chemotherapy, 2001
- The bacterial outer membrane as a drug barrierTrends in Microbiology, 1997
- Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1984
- Recent Studies on Albomycin, a New AntibioticBMJ, 1955